CLINICAL_TRIALS
trial_result
· 2012-09-12
Clinical Trial Update: Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg [Phase 2]
Summary
Phase 2 trial comparing the relative potency of Formoterol Novolizer 12 µg to Formoterol Aerolizer 12 µg in asthma shows completed results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2012-09-12